NCT04077723
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04077723
Title A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Englumafusp Alfa in Combination With Obinutuzumab and in Combination With Glofitamab Following a Pre-Treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NZL | ITA | GBR | FRA | ESP | DNK | CAN | BEL | AUS

Facility Status City State Zip Country Details
City of Hope Medical Center Pasadena California 91105 United States Details
University of California San Francisco San Francisco California 94158 United States Details
Colorado Blood Cancer Institute (CBCI) at Presbyterian/ St. Luke's Medical Center Denver Colorado 80218 United States Details
Beth Israel Medical Center Boston Massachusetts 02215 United States Details
Washington University School of Medicine St Louis Missouri 63110 United States Details
MSKCC New York New York 10065 United States Details
OhioHealth Research Institute Columbus Ohio 43221-2417 United States Details
SCRI Oncology Partners Nashville Tennessee 37203 United States Details
South Austin Medical Center Austin Texas 78704 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030-4009 United States Details
Peter Maccallum Cancer Centre Melbourne Victoria 3000 Australia Details
The Alfred Hospital Melbourne Victoria 3004 Australia Details
UZ Gent Ghent 9000 Belgium Details
Queen Elizabeth II Health Sciences Centre Halifax Nova Scotia B3H 2Y9 Canada Details
Jewish General Hospital Montreal Quebec H3T 1E2 Canada Details
Beijing Cancer Hospital Beijing 100142 China Details
Shandong Cancer Hospital Jinan 250117 China Details
Fudan University Shanghai Cancer Center Shanghai 201315 China Details
The First Affiliated Hospital of Xiamen University Xiamen 361003 China Details
Aarhus Universitetshospital Skejby Aarhus N 8200 Denmark Details
Rigshospitalet København Ø 2100 Denmark Details
Odense Universitetshospital Odense C 5000 Denmark Details
CHRU de Lille Lille 59037 France Details
CHU Montpellier - Saint ELOI Montpellier 34295 France Details
Centre Hospitalier Lyon Sud Pierre-Bénite 69495 France Details
CHU DE RENNES - CHU Pontchaillou Rennes 35033 France Details
Istituto Nazionale Tumori Irccs Fondazione g. Pascale Naples Campania 80131 Italy Details
Asst Papa Giovanni Xxiii Bergamo Lombardy 24127 Italy Details
Irccs Istituto Europeo Di Oncologia (IEO) Milan Lombardy 20141 Italy Details
Istituto Clinico Humanitas Rozzano Lombardy 20089 Italy Details
Auckland City Hospital, Cancer and Blood Research Auckland 1023 New Zealand Details
Waikato Hospital - Cancer and Blood Research Trials Unit Hamilton 3204 New Zealand Details
Pusan National University Hospital Busan 49241 South Korea Details
Seoul National University Hospital Seoul 03080 South Korea Details
Asan Medical Center Seoul 05505 South Korea Details
Samsung Medical Center Seoul 06351 South Korea Details
Hospital Duran i Reynals L'Hospitalet L'Hospitalet de Llobregat Barcelona 08908 Spain Details
Clinica Universitaria de Navarra Pamplona Navarre 31008 Spain Details
Hospital Universitari Vall d'Hebron Barcelona 08035 Spain Details
Clinica Universidad de Navarra Madrid Madrid 28027 Spain Details
Hospital Univ. 12 de Octubre Madrid 28041 Spain Details
Hospital Clinico Universitario Virgen de la Victoria Málaga 29010 Spain Details
The HOPE Clinical Trials Unit Leicester LE1 5WW United Kingdom Details
University College London Hospitals NHS Foundation Trust London W1T 7HA United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field